In addition, emerging research suggests that CDK5RAP3 may be involved in the regulation of hepatic, hematological and metabolic diseases due to the symptoms with liver degeneration, anemia, hemorrhage, and hypoglycemia, as well as impaired lipid metabolism and liver regeneration caused by its deficiency (21, 31). This evidence concerns the gene CDK5RAP3 and Hypoglycemia.